Earnings Feed
Start Free
Home/Filings/4/0001415889-24-028678
4//SEC Filing

Lowenthal Richard E 4

Accession 0001415889-24-028678

CIK 0001671858other
View on SEC.govCompany Profile

Filed

Dec 8, 7:00 PM ET

Accepted

Dec 9, 5:25 PM ET

Size

17.3 KB

Accession

0001415889-24-028678

Insider Transaction Report

Form 4
Period: 2024-12-06
ARS Pharmaceuticals, Inc.SPRY
Lowenthal Richard E
DirectorPRESIDENT AND CEO10% Owner
Transactions
  • Exercise/Conversion

    Stock Option (right to buy)

    2024-12-06−11,876→ 1,088,124 total
    Exercise: $8.42Exp: 2033-01-02→ Common Stock (11,876 underlying)
  • Exercise/Conversion

    Stock Option (right to buy)

    2024-12-06−13,789→ 20,684 total(indirect: By Spouse)
    Exercise: $1.44Exp: 2031-12-13→ Common Stock (13,789 underlying)
  • Exercise/Conversion

    Stock Option (right to buy)

    2024-12-06−11,876→ 338,124 total(indirect: By Spouse)
    Exercise: $8.42Exp: 2033-01-02→ Common Stock (11,876 underlying)
  • Exercise/Conversion

    Common Stock

    2024-12-06$1.44/sh+13,789$19,856→ 3,421,636 total(indirect: By Spouse)
  • Exercise/Conversion

    Common Stock

    2024-12-06$8.42/sh+11,876$99,996→ 4,327,189 total
  • Exercise/Conversion

    Common Stock

    2024-12-06$8.42/sh+11,876$99,996→ 3,433,512 total(indirect: By Spouse)
Holdings

  • Common Stock

    (indirect: By Trust)
    1,347,447

  • Common Stock

    (indirect: By Trust)
    1,296,494

  • Common Stock

    (indirect: By Trust)
    1,198,499
Footnotes (4)
  • [F1]The Reporting Person is trustee of the trust.
  • [F2]The shares are held in trust for the benefit of the Reporting Person and his spouse. The Reporting Person and his spouse are trustees of the trust.
  • [F3]The Reporting Person's spouse is trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
  • [F4]25% of the shares subject to the option vested on the one year anniversary of the vesting commencement date and the balance of the shares vest in a series of thirty-six (36) successive equal monthly installments measured from the first anniversary of the vesting commencement date.

Documents

1 file

Issuer

ARS Pharmaceuticals, Inc.

CIK 0001671858

→
Entity typeother

Related Parties

1
  • filerCIK 0001378550

Filing Metadata

Form type
4
Filed
Dec 8, 7:00 PM ET
Accepted
Dec 9, 5:25 PM ET
Size
17.3 KB
View on SEC.gov